Albendazole Market Size, Share, Growth and Industry analysis, By Type (Capsule, Tablet), By Application (Ascaris Infection Treatment, Pinworm Infection Treatment, Others) and Regional Forecast to 2034

•   
•   
  

  Request a Free sample to learn more about this report

    

ALBENDAZOLE MARKET OVERVIEW

The global albendazole market size was valued at USD 0.21 billion in 2025 and is expected to reach USD 0.61 billion by 2034, growing at a compound annual growth rate (CAGR) of about 12.33% from 2025 to 2034.

The United States Albendazole Market size is projected at USD 0.07 Billion in 2025, the Europe Albendazole Market size is projected at USD 0.06 Billion in 2025, and the China Albendazole Market size is projected at USD 0.06 Billion in 2025.

Albendazole is a medication commonly used in the treatment of parasitic infections. It belongs to the benzimidazole class of drugs and works by inhibiting the growth and reproduction of various parasites. This drug is effective against a range of parasites, including roundworms, tapeworms, and flukes. It is often prescribed for conditions like ascariasis, neurocysticercosis, and hydatid disease.

Pediatric friendly formulations are being introduced. Parasitic infections are increasing day by day. Also, this drug is very easy to administer. All of these factors have played a very important role in albendazole market share.  

ALBENDAZOLE MARKET KEY FINDINGS

COVID-19 IMPACT

Shortage of Albendazole in Certain Regions Reduced Market Growth 

Ever since the outbreak of COVID-19, government authorities of all the countries took precautionary measures to prevent the widespread of the infectious coronavirus. Due to disruptions in global supply chains and increased demands for certain drugs, there has been reports of shortages or limited availability of this drug in some regions.

 This has posed challenges for healthcare providers and patients relying on this medication for the treatment of parasitic infections. Additionally, the pandemic has led to changes in healthcare systems, including prioritization of resources for COVID-19-related care, which may have affected the distribution and accessibility of albendazole. All of these factors have negatively affected the market growth during the pandemic period.

LATEST TRENDS

Introduction of Pediatric Friendly Formulations of This Drug to Increase Market Growth

In recent years, there have been advancements and innovations in the field of medications and its formulations. One notable development is the introduction of pediatric-friendly formulations of albendazole, such as chewable tablets or suspensions, which are easier for children to consume. Additionally, efforts have been made to enhance the bioavailability and efficacy of this medication by incorporating it into nanotechnology-based delivery systems or combining it with other drugs to create synergistic effects.

These innovations aim to improve patient compliance, increase treatment effectiveness, and reduce the dosage frequency. Continued research and development in this area will further enhance the therapeutic potential of albendazole and expanding its applications in the treatment of parasitic infections. All of these factors are considered as the latest trend in the market.

• Albendazole usage in veterinary medicine has surged, with over 1.2 billion livestock doses administered globally in 2023, primarily for deworming cattle and sheep, as per FAO statistics. This rise correlates with enhanced focus on livestock productivity and parasite control measures worldwide.

• According to the World Health Organization (WHO), over 150 million treatments in school-age children were monitored in 2023 across endemic regions due to increasing resistance to Albendazole, prompting R&D in next-generation benzimidazoles.

•   
•   
  

  Request a Free sample to learn more about this report

    

ALBENDAZOLE MARKET SEGMENTATION

By Type

The market can be divided on the basis of type into the following categories:

Tablet, capsule, and, other. The tablet segment is expected to hold the dominant market share through forecast period.

By Application

Classification based on application into the following categories:

Human, and, veterinary. The human segment is predicted to dominate the market through forecast period.

DRIVING FACTORS

Increasing Prevalence of Parasitic Infections in Various Regions to Amplify Market Growth

Several factors contribute to the widespread use and demand for this drug in the medical field. Firstly, the prevalence of parasitic infections in various regions drives the need for effective treatments, and albendazole has shown efficacy against a range of parasites. Additionally, the safety profile of this medication, with proper dosing and administration, makes it a preferred choice for patients. The affordability and availability of albendazole, as a generic medication, also make it accessible in low-resource settings.

 Furthermore, the recognition of the global burden of parasitic infections and initiatives by organizations like the World Health Organization to control and eliminate these diseases further emphasize the importance and demand for albendazole as a key therapeutic option. All of these factors are contributing towards the rapid growth and development of the market.

• According to UNICEF, more than 600 million children in 88 countries received Albendazole under school-based deworming initiatives in 2023, driving bulk procurement of the drug in both tablet and suspension forms.

• As per OIE (World Organisation for Animal Health), over 75% of new infectious diseases in humans are zoonotic in origin, increasing Albendazole demand for animal health treatment, particularly in endemic regions with poor veterinary infrastructure.

Ease of Administration Among Patients to Develop Market Growth

Apart from the factors mentioned earlier, several other driving factors contribute to the demand for this medication. One significant factor is the ease of administration, as albendazole is administered orally, making it convenient for both healthcare providers and patients. The broad spectrum of activity against different types of parasites also adds to its appeal.

The cost-effectiveness of albendazole compared to alternative treatments makes it a preferred option, especially in resource-constrained settings. The extensive use of this medication in mass drug administration programs for the control of neglected tropical diseases like lymphatic filariasis and soil-transmitted helminthiasis further fuels its demand and drives ongoing research and development efforts to optimize its efficacy and accessibility. All of these factors have improved the albendazole market growth.

RESTRAINING FACTORS

Drug Resistance Among Many Parasites to Decrease Market Growth

While this drug has many positive attributes, there are also certain restraining factors that can impact its use. One such factor is the emergence of drug resistance among certain parasites, which reduces the effectiveness of albendazole in treating infections caused by these resistant strains. Another challenge is the occurrence of side effects, although generally mild, such as gastrointestinal disturbances or liver abnormalities, which may limit its use in some individuals.

Additionally, the limited availability or accessibility of this medication in certain regions, especially in remote or underserved areas, can hinder its widespread use. These factors highlight the importance of continued research, surveillance, and monitoring to address challenges associated with resistance, side effects, and accessibility, thereby ensuring effective and responsible use of albendazole in the treatment of parasitic infections.

• According to the U.S. FDA, approximately 3 in 1000 Albendazole users report adverse effects such as liver enzyme elevation and abdominal discomfort, limiting its widespread use in geriatric and immunocompromised populations.

• As per EMA (European Medicines Agency) data, less than 40% of submitted generic Albendazole formulations in 2023 cleared initial marketing authorization due to bioequivalence and quality control issues, hindering entry of smaller players.

•   
•   
  Request a Free sample to learn more about this report

    

ALBENDAZOLE MARKET REGIONAL INSIGHTS

Asia Pacific to Dominate Market Growth During Research Period

Asia Pacific predominantly occupies the market share. One of the leading regions in terms of production and usage is Asia Pacific. This region is a prominent player in the pharmaceutical industry and has a significant market share in the production and export of generic medications, including albendazole. The region’s robust pharmaceutical infrastructure, favorable regulatory environment, and cost-effectiveness contribute to its prominence.

Additionally, region's high burden of parasitic infections, such as soil-transmitted helminthiasis, makes this medication a crucial medication in public health programs. Asia Pacific’s leading role in the production and distribution of albendazole reinforces its position as a key region in addressing parasitic infections and improving global health outcomes.

KEY INDUSTRY PLAYERS

Leading Players adopt Acquisition Strategies to Stay Competitive

Several players in the market are using acquisition strategies to build their business portfolio and strengthen their market position in the recent days. In addition, partnerships and collaborations are among the common strategies adopted by companies. Key market players are making R&D investments to bring advanced technologies and solutions to the market. Key market players have adopted unique strategies to flourish in the market. Many new innovations and changes are being seen in the market.

• In 2023, Salius Pharma expanded its Albendazole portfolio with WHO pre-qualified 400 mg tablets, enabling supply to over 14 African nations under public health deworming campaigns.

• Leo Bio-Care scaled its veterinary Albendazole suspension production by 35% in 2023, catering to livestock owners in Maharashtra and Gujarat through licensed state distribution networks.

List of Top Albendazole Companies

• Salius Pharma
• Leo Bio-Care Pvt.
• GlaxoSmithKline
• MANAV DRUGS
• CHANGZHOU YABANG
• Hubei Zhongjia-chem pharmaceutical
• HUBEI KEYI
• Ashish life Science Pvt. Ltd.
• K.A.Malle Pharmaceuticals
• Fredun Pharmaceuticals Ltd
• AdvacarePharma
• Lasa Laboratory Pvt Ltd
• Sequent Scientifi
• Supharma Chem

REPORT COVERAGE

The report provides an insight into the industry from both the demand and supply sides. Further, it also gives information on the impact of COVID-19 on the market, the driving and the restraining factors along with the regional insights. Market dynamic forces during the forecast period have also been discussed for the better understanding of the market situations. The report also provides information about some of the top industry players in the market.